Abstract:Importance: Prior studies have demonstrated lower all-cause mortality in individuals who are overweight compared with those with normal body mass index (BMI), but whether this may come at the cost of greater burden of cardiovascular disease (CVD) is unknown.Objective: To calculate lifetime risk estimates of incident CVD and subtypes of CVD and to estimate years lived with and without CVD by weight status.Design, Setting, and Participants: In this population-based study, we used pooled individual-level data from adults (baseline age, 20-39, 40-59, and 60-79 years) across 10 large US prospective cohorts, with 3.2 million person-years of follow-up from 1964 to 2015. All participants were free of clinical CVD at baseline with available BMI index and CVD outcomes data. Data were analyzed from October 2016 to July 2017.Exposures: World Health Organization-standardized BMI categories.Main Outcomes and Measures: Total CVD and CVD subtype, including fatal and nonfatal coronary heart disease, stroke, congestive heart failure, and other CVD deaths. Heights and weights were measured directly by investigators in each study, and BMI was calculated as weight in kilograms divided by height in meters squared. We performed (1) modified Kaplan-Meier analysis to estimate lifetime risks, (2) adjusted competing Cox models to estimate joint cumulative risks for CVD or noncardiovascular death, and (3) the Irwin restricted mean to estimate years lived free of and with CVD.Results: Of the 190 672 in-person examinations included in this study, the mean (SD) age was 46.0 (15.0) years for men and 58.7 (12.9) years for women, and 140 835 patients (73.9%) were female. Compared with individuals with a normal BMI (defined as a BMI of 18.5 to 24.9), lifetime risks for incident CVD were higher in middle-aged adults in the overweight and obese groups. Compared with normal weight, among middle-aged men and women, competing hazard ratios for incident CVD were 1.21 (95% CI, 1.14-1.28) and 1.32 (95% CI, 1.24-1.40), respectively, for overweight (BMI, 25.0-29.9), 1.67 (95% CI, 1.55-1.79) and 1.85 (95% CI, 1.72-1.99) for obesity (BMI, 30.0-39.9), and 3.14 (95% CI, 2.48-3.97) and 2.53 (95% CI, 2.20-2.91) for morbid obesity (BMI, ≥40.0). Higher BMI had the strongest association with incident heart failure among CVD subtypes. Average years lived with CVD were longer for middle-aged adults in the overweight and obese groups compared with adults in the normal BMI group. Similar patterns were observed in younger and older adults.Conclusions and Relevance: In this study, obesity was associated with shorter longevity and significantly increased risk of cardiovascular morbidity and mortality compared with normal BMI. Despite similar longevity compared with normal BMI, overweight was associated with significantly increased risk of developing CVD at an earlier age, resulting in a greater proportion of life lived with CVD morbidity.

Effect of body mass index on mortality for diabetic patients with aortic stenosis

Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity

Effect of Elevated Body Mass Index on Outcomes of Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis

Impact of Body Mass Index on Perioperative Mortality of Acute Stanford Type A Aortic Dissection: a Systematic Review and Meta-Analysis

The Impact of Body Mass Index on the Mortality of Myocardial Infarction Patients With Nonobstructive Coronary Arteries

The Association between Body Mass Index and All-Cause Mortality in Type 2 Diabetic Inpatients With and Without Diabetic Microangiopathy—A Retrospective Cohort

Adiposity and risks of vascular and non-vascular mortality among Chinese adults with type 2 diabetes: a 10-year prospective study

The Role of Increased Body Mass Index in Outcomes of Sepsis: a Systematic Review and Meta-Analysis

The effect of body mass index on stroke prognosis: A systematic review and meta-analysis of 32 cohort studies with 330,353 patients

Overweight is Associated with Better One-Year Survival in Elderly Patients after Cardiac Surgery: a Retrospective Analysis of the MIMIC-III Database

Body Mass Index and the Risk of All-Cause Mortality among Patients with Type 2 Diabetes Mellitus

Abstract 06: Body Mass Index and the Risk of All-cause Mortality among Patients with Type 2 Diabetes

Body Mass Index and Mortality Risk in Asian Peritoneal Dialysis Patients in Hong Kong—Impact of Diabetes and Cardiovascular Disease Status

Impact of body mass index on mortality in patients undergoing elective percutaneous coronary intervention

Association and Time-Varying Effects of Body Mass Index on All-Cause Mortality in Patients With Hypertension

Prognostic Impact of Body Mass Index in Atrial Fibrillation

Abstract W P159: Impact of Body Mass Index on 1-Year Outcome after Acute Ischemic Stroke

Mortality is lowest in overweight followed by obese and morbid obese patients and is highest in cachexia compared to normal weight in patients with the diagnosis of aortic stenosis.

Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial

Extent and impact of obesity in patients with diabetes and acute myocardial infarction - experience from a national cohort

Clinical impact of body mass index on outcomes of ischemic and hemorrhagic strokes